O'Connor Donal — SEC insider filings

SEC reporting owner CIK 1625377. 16 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2021-04-29 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PERRIGO Co plc (PRGO)Director8——24
Theravance Biopharma, Inc. (TBPH)Director8——24

Insider filings — O'Connor Donal

FiledFormIssuerReported transactionsSource
2026-09-244Theravance Biopharma, Inc. (TBPH)Disposition to issuer (D): 74,204 · Disposition to issuer (D): 6,009 · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · +5 moreEDGAR
2026-06-164Theravance Biopharma, Inc. (TBPH)Grant/award (A): 6,009 @ $0 · Grant/award (A): 13,398 (derivative) @ $0EDGAR
2026-05-154PERRIGO Co plc (PRGO)Option exercise (M): 7,305 @ $10.84 · Tax withholding (F): 3,507 @ $10.84 · Grant/award (A): 16,681 (derivative) · Option exercise (M): 7,305 (derivative)EDGAR
2025-05-214Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,649 @ $0 · Grant/award (A): 24,258 (derivative) @ $0EDGAR
2025-05-164PERRIGO Co plc (PRGO)Option exercise (M): 9,904 @ $26.01 · Tax withholding (F): 4,754 @ $26.01 · Grant/award (A): 7,305 (derivative) · Option exercise (M): 9,904 (derivative)EDGAR
2024-05-164PERRIGO Co plc (PRGO)Option exercise (M): 8,764 @ $30.22 · Tax withholding (F): 4,207 @ $30.22 · Grant/award (A): 9,904 (derivative) · Option exercise (M): 8,764 (derivative)EDGAR
2024-05-104Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,537 @ $0 · Grant/award (A): 23,576 (derivative) @ $0EDGAR
2023-05-194PERRIGO Co plc (PRGO)Option exercise (M): 7,778 @ $32.86 · Tax withholding (F): 3,734 @ $32.86 · Option exercise (M): 7,778 (derivative)EDGAR
2023-05-174PERRIGO Co plc (PRGO)Grant/award (A): 8,764 (derivative)EDGAR
2023-05-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,132 @ $0 · Grant/award (A): 22,044 (derivative) @ $0EDGAR
2022-11-234Theravance Biopharma, Inc. (TBPH)Disposition to issuer (D): 10,000 @ $10.50EDGAR
2022-05-194PERRIGO Co plc (PRGO)Option exercise (M): 6,599 @ $38.57 · Tax withholding (F): 3,168 @ $38.57 · Grant/award (A): 7,778 (derivative) · Option exercise (M): 6,599 (derivative)EDGAR
2022-04-284Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,852 @ $0 · Grant/award (A): 28,000 (derivative) @ $0EDGAR
2021-05-194PERRIGO Co plc (PRGO)Grant/award (A): 6,599 (derivative)EDGAR
2021-05-114PERRIGO Co plc (PRGO)Option exercise (M): 5,804 @ $42.96 · Tax withholding (F): 2,786 @ $42.96 · Option exercise (M): 5,804 (derivative)EDGAR
2021-04-294Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,828 @ $0 · Grant/award (A): 6,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1625377 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs